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Small immune complexes cause type III hypersensitivity reactions that frequently result in tissue 
injury. The responsible mechanisms however remain unclear and differ depending on target 
organs. Here we identify a kidney-specific anatomical and functional unit, formed by resident 
macrophages and peritubular capillary endothelial cells, which monitors the transport of proteins 
and particles ranging from 20 to 700 kDa or 10 to 200 nm into the kidney interstitium. Kidney 
resident macrophages detect and scavenge circulating immune complexes ‘pumped’ into the 
interstitium via trans-endothelial transport, and trigger a FcγRIV-dependent inflammatory 
response and the recruitment of monocytes and neutrophils. In addition, FcγRIV and TLR 
pathways synergistically ‘super-activate’ kidney macrophages when immune complexes contain a 
nucleic acid. These data identify a physiological function of tissue resident kidney macrophages 
and a basic mechanism by which they initiate the inflammatory response to small immune 
complexes in the kidney.
Graphical Abstract
INTRODUCTION
Opsonization of microbial pathogens by immunoglobulins results in immune complexes that 
are cleared by the innate immune system via binding to Fc receptors (FcRs), complement 
activation, natural killer (NK)-cell mediated killing, and via phagocytosis by macrophages in 
the spleen and liver (Bournazos et al., 2015; Guilliams et al., 2014; Nimmerjahn and 
Ravetch, 2007; Schifferli and Taylor, 1989; Vidarsson and van de Winkel, 1998). However, 
low molecular weight immune complexes (referred to below as small immune complexes, 
SIC) are believed to be less efficiently cleared by liver and spleen macrophages, which can 
result in the activation of neutrophils and monocytes (Jancar and Crespo; Jönsson et al., 
2013; Mayadas et al., 2009), complement (Merle et al., 2015), endothelial cells (Sun et al., 
2013) and mast cells (Daha et al., 1988). Immune complexes also deposit in tissues, either as 
a result of increased vascular permeability or tissue damage (Binstadt et al., 2006; Stokol et 
al., 2004).
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Clinical conditions caused by SIC are collectively known as ‘Type III hypersensitivity’ 
reactions and include the Arthus reaction, serum sickness, post-streptococcal 
glomerulonephritis, cryoglobulinemia, rheumatoid arthritis, and Systemic Lupus 
Erythematosus (SLE) (Froehlich and Verma, 2001; Lamprecht et al., 1999; Mayadas et al., 
2009; Nimmerjahn and Ravetch, 2007; Schifferli and Taylor, 1989; Vidarsson and van de 
Winkel, 1998). Type III hypersensitivity can be experimentally induced by immune 
complexes formed in excess of self and foreign antigens, including proteins, (deoxy)ribo-
nucleo-proteins, and drugs. Mice deficient in the activating receptors for the Fc portion of 
immunoglobulin G (FcγRs) are protected from acute and progressive glomerulonephritis, 
arthritis, SLE nephritis, and the Arthus reaction (Nimmerjahn and Ravetch, 2008), 
suggesting that activating FcγRs expressed by cells of the innate immune system play a 
major role in type III hypersensitivity.
However, the mechanisms that control type III hypersensitivity remain poorly understood, 
and different mechanisms may mediate the toxicity of SIC in distinct vascular beds. SIC can 
bind to the endothelium, in particular following complement activation (Daha et al., 1988) 
and directly trigger increased vascular permeability in vascular beds adjacent to joints, but 
not the skin or intestine (Binstadt et al., 2006). The Arthus reaction, which results from 
formation of antigen/antibody complexes in situ in the dermis after the intradermal injection 
of an antigen, is dependent on mast cells, the murine FcγRIII and FcεRI expressed by mast 
cells, and is independent of FcγRIV and complement (Hazenbos et al., 1996; Nimmerjahn et 
al., 2010; Sylvestre and Ravetch, 1994; Sylvestre and Ravetch, 1996). In contrast, mast cell 
deficiency does not modify the pathogenesis of Lupus glomerulonephritis in B6lpr/lpr mice 
(van Nieuwenhuijze et al., 2015). The murine intermediate/low-affinity IgG receptor 
FcγRIV - ortholog of human FcγRIIIa (Davis et al., 2002; Mechetina et al., 2002) - 
expressed by granulocytes, monocytes and macrophages is sufficient for autoantibody-
induced nephrotoxic nephritis, rheumatoid arthritis and experimental epidermolysis bullosa 
acquisita (Kasperkiewicz et al., 2012; Mancardi et al., 2011; Nimmerjahn et al., 2010).
The role of tissue macrophages in type III hypersensitivity is largely unknown, beyond their 
reported ‘inefficiency’ to clear SIC. Recent progress in the developmental biology of 
myeloid cells has led to the concept that two lineages of myeloid cells may exert distinct 
functions within tissues. Resident macrophages, which develop during embryogenesis, are 
likely to mediate homeostatic ‘housekeeping’ functions, such as the phagocytosis of 
opsonized particles, while leucocytes that differentiate in the bone marrow and are recruited 
into tissues from the blood – including neutrophils, monocytes, and dendritic cells – are 
likely to be primarily involved in the innate immune response (Gomez Perdiguero and 
Geissmann, 2013; Yamasaki et al., 2014).
To interrogate the respective contribution of resident versus bone marrow (BM)-derived cells 
to Type III hypersensitivity in mice, we investigated in vivo the distribution, kinetics of 
uptake and responses to SIC by resident macrophages and bone marrow-derived leucocytes. 
Our data indicate that Kupffer cells (KC) and spleen red pulp macrophages (RPMΦs) 
rapidly take up circulating SIC as well as large particles, such as 2 μm latex beads, as 
expected since they are located within sinusoidal (sieved) endothelia and sample the 
bloodstream. Surprisingly however, the resident macrophage population of the kidney also 
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takes up circulating SIC as efficiently and rapidly as spleen and liver macrophages, even 
though it does not take up large circulating beads. SIC uptake by kidney macrophages is 
mediated by FcγRIV and triggers an inflammatory response that is characterized by 
cytokine production and is required for the recruitment of blood monocytes and neutrophils. 
These features appear to be specific to the kidney as dermal macrophages, for example, 
neither efficiently take up SIC nor mediate an inflammatory response to SIC in vivo. We 
found that this response of kidney macrophages resulted from their unique anatomical 
location, at the abluminal side of the endothelium of peritubular capillaries, where they 
actively monitor the trans-endothelial transport of albumin that takes place between the 
capillaries and the peritubular interstitial space (Bell et al., 1978; Källskog and Wolgast, 
1973; Pinter, 1967; Pinter and O’Morchoe, 1970). These data identify a unique property of 
kidney macrophages, i.e. the immune monitoring of trans-endothelial transport into the 
kidney interstitium, and provide a mechanism for the initiation of type III hypersensitivity in 
the kidney and the pathogenesis of kidney damage by small circulating immune complexes.
Results
Kidney macrophages take up circulating small soluble immune complexes (SIC)
To probe uptake of circulating proteins and small immune complexes by tissue macrophages 
and blood leucocytes in vivo, we initially followed the uptake of fluorescent bovine serum 
albumin (BSA) or chicken ovalbumin (OVA), and small immune complexes (SIC) prepared 
by incubating rabbit polyclonal immunoglobulin G (IgG) against bovine serum albumin 
(RaBSA) or chicken ovalbumin (RaOVA) with an excess of BSA or OVA (Clatworthy et al., 
2014; Stokol et al., 2004) (Figure S1A). Rabbit IgG bind FcγRI and FcγRIV with KD of 
10−7–10−8 and FcγRIIb/III with KD of 10−5, and ~20% of IgG was bound to albumin to 
form ~700 kDa SIC (Figures S1A and S1B). Following intravenous (i.v.) injection of 
fluorescent albumin and SIC, fluorescence accumulated in F4/80bright macrophages in the 
spleen (red pulp macrophages, RPMΦs), the liver (Kupffer cells) and the kidney (Figures 1A 
and 1B), but there was no detectable uptake of fluorescent albumin or SIC by dermal 
macrophages, epidermal Langerhans cells, alveolar macrophages and microglia (Figure 1A). 
Uptake of fluorescent albumin and SIC by kidney, liver and spleen macrophages was time- 
and dose- dependent, and uptake of SIC was more efficient than uptake of albumin alone 
(Figures 1C, 1D and S1C–S1F). In contrast, uptake of fluorescent albumin or SIC by 
monocytes (F4/80intCD11bhigh cells) and granulocytes (F4/80−CD11bhigh cells) was not 
significant (Figures 1B–1D and S1C).
To verify that immune complexes, rather than unbound antibodies, were responsible for the 
increased uptake of albumin by kidney macrophages, we compared uptake of ‘mock’ 
immune complexes (BSA;RaOVA) versus BSA;RaBSA SIC. These experiments indicated 
that anti-OVA antibodies do not increase BSA uptake (Figure 1E), thus antibody-antigen 
complexes are required to increase the scavenging by macrophages. Flow cytometry analysis 
of kidney macrophages following i.v. injection of BSA-alexa488;RaBSA and 
immunostaining with a goat anti-rabbit-alexa555 also indicated that kidney macrophages 
take up SIC preferentially to albumin alone (Figure S1G).
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Intravital microscopy and flow cytometry analysis indicated uptake of SIC by macrophages 
within vesicular (Figure 1F) and acidic compartments (Figure 1G) as shown by uptake of 
DQ-BSA;RaBSA (Phan et al., 2009). Following i.v. injection of SIC, immunofluorescence 
on fixed kidney cryosections with antibodies against F4/80 and rabbit IgG showed that the 
macrophages that take up SIC are located close to endothelial cells, around tubules and 
around glomeruli (Figures 2A and S2A–S2C, see also Figure 3). We also observed that 
dense periglomerular and peritubular IgG2a deposits colocalized with F4/80 staining in 
cryosections from kidneys of autoimmune NZB/W mice, but not wild-type (wt) C57BL/6 
mice (Figures 2B and S2D).
These results altogether indicated that Kupffer cells and RPMΦs efficiently take up 
circulating SIC, and that this is also the case for kidney macrophages in these experimental 
settings and possibly in ‘autoimmune’ NZB/W mice. The sinusoidal endothelium of the liver 
and the spleen red pulp allows for direct contact between Kupffer cells and RPMΦs with the 
bloodstream (Aird, 2007; Mebius and Kraal, 2005), but this is not the case for kidney 
macrophages. We thus investigated whether uptake selectively takes place in the kidney, or if 
blood leucocytes take up SIC and subsequently migrate into the kidney.
Kidney F4/80bright cells are tissue resident macrophages that actively survey the 
microvascular environment
Kidney F4/80bright macrophages were initially described by Hume and Gordon (Hume and 
Gordon, 1983) and present with features of both dendritic cells and macrophages 
(Gottschalk and Kurts, 2015). To further characterize these cells, we analyzed them by flow 
cytometry, immunofluorescence, intravital confocal microscopy and RNAseq analysis. 
F4/80bright cells constitute ~ 50% of CD45+ cells in the kidney of C57BL/6 mice (Figure 
S2E) and express MHC class II (I-A), Cx3cr1, and CD11c (Figure S2F) in agreement with 
previous reports (Cao et al., 2015; Krüger et al., 2004). They also express Fcγ receptors, 
including FcγRIV in contrast to skin macrophages, microglia and kidney endothelial cells 
(Figures 2C and S2F–S2H). Analysis of parabiotic mice paired for up to 2 months showed 
that less than 1% of kidney F4/80bright cells exchange between parabionts, in contrast to 
blood monocytes (Figure 2D). Accordingly, kidney F4/80bright cells are Ccr2 independent 
(Figure S2I).
Intravital microscopy of the superficial renal cortex in Cx3cr1gfp/+ mice confirmed that the 
resident macrophages form a dense network of interstitial stellate cells in close association 
with capillaries that surround the tubules and glomeruli (Figure 2E and supplementary 
movies S1 and S2) (Hume and Gordon, 1983; Soos et al., 2006). Resident macrophages 
were found to be stationary with their cell bodies not moving over a 5 hour timeframe in 
>95% of cases (Figures S2J and S2K). They dynamically surveyed the microvascular 
environment (Figure 2F and supplementary movie S3) using their long (>30 μm) and highly 
motile filopodia, which extended along the capillary walls and can form phagocytic cups to 
mediate engulfment of bacteria and fungi (Figures S2L and S2M).
Altogether, these data indicated that F4/80bright Cx3cr1gfp+ cells are tissue-resident 
macrophages and not infiltrating monocytes or bone marrow-derived dendritic cells (Liu et 
al., 2007), located in the immediate vicinity of the microvasculature, and that actively survey 
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their environment We therefore investigated the mechanisms that may account for the uptake 
of circulating SIC.
Kidney resident macrophages are located between the capillary endothelium and the 
basement membranes of tubules and the Bowman capsule
Although confocal microscopy suggested that resident macrophages are located very close 
to the lumen of peritubular capillaries (Figure 3A), its resolution is limited. Transmission 
electron microscopy (TEM) showed that the filopodial extensions of macrophages, 
immunolabeled with either anti-GFP antibodies in Cx3cr1gfp+ mice or anti-I-A antibodies in 
wt mice, are located at the abluminal side of the peritubular capillary, often directly apposed 
to the abluminal endothelial cell surface and between these endothelial cells and the 
basement membranes of proximal and distal tubules and the Bowman capsule (Figures 3B–
3H and S3A–S3C). These features are distinct from the microanatomy of the dermis, where 
macrophages are separated from the endothelium by a basement membrane (Freinkel and 
Woodley, 2001).
Kidney resident macrophages monitor vesicular trans-endothelial transport of proteins
In agreement with classical studies (Milici et al., 1987; Predescu and Palade, 1993; Schubert 
et al., 2001) TEM revealed that peritubular capillaries are rich in caveolae (Figure 3B), 
transendothelial channels, and clathrin coated vesicles (CCV) and present with diaphragm-
subtended fenestrae (Aird, 2007) (Figures 3B–3G). Ultrastructural analyses performed on 
the kidney of mice sacrificed 1 minute after i.v. injection of BSA-immunogold indicated the 
presence of immunogold in endothelial caveolae (Figure S4A) as well as in macrophage 
endosomal compartments (Figure S4A). Intravital confocal imaging confirmed uptake of 
OVA by macrophages within 1–5 minutes of i.v. injection (Figure 4A and supplementary 
movie S4). This is in accordance with previous studies (see discussion) showing extensive 
albumin transport from capillaries to the interstitium mediated via caveolae/CCV (Milici et 
al., 1987; Predescu and Palade, 1993; Schubert et al., 2001). We thus hypothesized that the 
endothelial/macrophage structure we describe above may allow for the immune monitoring 
of trans-endothelial transport by the resident kidney macrophages. We therefore quantified 
the kinetics and morphological aspects of the transport of antibodies and immune complexes 
from the lumen to the macrophages.
Labeling of perivascular macrophages was detectable by intravital confocal microscopy 
within minutes after i.v. injection of 10 μg of phycoerythrin (PE)- conjugated anti-F4/80 or 
anti-I-A antibodies (MW ~ 450 kDa, Figure 4B and supplementary movies S5 and S6). This 
was confirmed by flow cytometry, as >95% of kidney macrophages from mice sacrificed 5 
minutes after i.v. injection of 10 μg anti-I-A antibody were observed to be labeled in vivo 
(Figure 4C). To distinguish caveolae/CCV mediated transport (Aird, 2007; Stan et al., 1999; 
Stan et al., 2012) from vascular leakage mediated in response to SIC binding to the 
endothelium (Binstadt et al., 2006) or the projection of filopodia in the capillary lumen 
(Cheng et al., 2013), mice were sacrificed 30 seconds after i.v. injection of OVA;RaOVA and 
their kidneys were processed for TEM and labeled with Goat anti Rabbit (GaR) conjugated 
with gold particles. Quantitative analysis revealed that 10% of gold particles localized to the 
endothelium. Among these, 96% of gold particles were found within endothelial caveolae/
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CCV, while only ~ 4% of gold particles were located nearby cellular junctions or 
diaphragm-subtended fenestrations (Figures 4D, 4E and S4C). 25% of gold particles were 
attached to macrophages and observed within their endosomal compartments. 60% of gold 
particles were localized to the interstitial space or to basement membranes (Figure 4E). 
Intravital imaging directly showed that kidney macrophages take up 20 nm beads by their 
motile filopodia (Figure 4F and supplementary movie S7), but we did not observe any 
filopodia extruded into the capillary lumen by TEM.
To formally investigate whether uptake by macrophages in vivo was restricted to circulating 
particles of a size compatible with trans-endothelial transport, we quantified uptake of 2 μm, 
200 nm and 20 nm latex beads injected intravenously. Results indicated that kidney 
macrophages only take up beads of 200 nm and 20 nm, in contrast to RPMΦs and blood 
monocytes which are able to take up larger 2 μm beads (Figures 4G and S4D). Finally, to 
test the possibility that SIC binding to the endothelium may induce vascular leakage we 
investigated by intravital imaging the extravasation of 70 kDa dextran-TRITC following i.v. 
injection of BSA;RaBSA (Binstadt et al., 2006). We did not observed measurable leakage in 
vivo following BSA;RaBSA injection (Figures 4H and S4E).
Altogether, these results provided strong evidence that antibodies and SIC (~700 kDa) are 
transcytosed into the kidney interstitium via the transendothelial route of albumin transport 
(Milici et al., 1987) mediated by caveolae/CCV, and that SIC are immediately scavenged by 
the kidney resident macrophages. In contrast to Kupffer cells and RPMΦs, which 
phagocytose large particles and immune complexes from the bloodstream, selective 
scavenging of SIC by kidney macrophages indicates a function restricted to the survey of 
endothelial transport and of the kidney interstitium.
Fcgr4-mediated uptake and activation of kidney macrophages by immune complexes
Next we sought to investigate whether Fcγ receptors were required for uptake of SIC by 
kidney macrophages. We found that FcγRIV is required while FcγRI (CD64) was 
dispensable (Figures 5A, 5B and S5A). FcγRIV is not expressed by kidney endothelial cells 
(Figure S2H) and conditional inactivation of the Fcgr4 gene in hematopoietic cells in 
Csf1rCre+;Fcgr4f/f and LysMCre+;Fcgr4f/f mice was sufficient to reduce SIC uptake to control 
levels in kidney macrophages, as well as Kupffer cells (Figures 5A, 5B and S5A). SIC 
uptake was in contrast independent of Myd88 or Trif, suggesting that scavenging is not 
dependent on a Toll-like receptor-mediated signal, such as endotoxin (Pandey et al., 2015) 
(Figure S5B).
These data indicated that FcγRIV mediates scavenging by kidney macrophages of immune 
complexes that enter the kidney interstitium via trans-endothelial transport. Complexed IgG 
or immune complexes alone do not elicit an inflammatory response from monocyte-derived 
macrophages in vitro in the absence of a TLR agonist (Sutterwala et al., 1997; Vogelpoel et 
al., 2014). Nevertheless, we found that SIC uptake in vivo caused a rapid FcγRIV-dependent 
and Myd88-independent transcriptional inflammatory response by kidney macrophages 
(Figures 5C, 5D and S5C). The production of TNF by kidney macrophages was confirmed at 
the protein level and was strongly reduced in Fcgr4-deficient mice but not in Myd88-
deficient mice (Figures 5E, 5F and S5D). In contrast, i.v. injection of SIC did not trigger 
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TNF production by dermal macrophages (Figure 5G), a finding consistent with the 
observation that they do not scavenge SIC (Figure 1A). Blood monocytes and granulocytes 
did not significantly produce TNF either (Figure 5F). Following SIC uptake kidney 
macrophages also expressed increased levels of activation molecules CD86 and MHCII, in a 
FcγRIV-dependent and Myd88-independent manner (Figure S5E, S5F and S5G).
To test the possibility that macrophage activation may be in part dependent on in vitro 
preparation of SIC (Poteser and Wakabayashi, 2004), we compared the effect of i.v. injection 
of BSA, RaBSA, BSA;RaBSA, non-immune rabbit IgG (Ra-IgG), rabbit anti-mouse 
albumin (Ra-mAlbumin), rabbit anti-mouse transferrin (Ra- mTransferrin), rabbit anti-
mouse IgG (Ra-mIgG) and Ra-mIgG F(ab′)2. Macrophage activation and TNF production 
was observed only in presence of rabbit whole IgG complexed with foreign antigens or 
directed against mouse albumin, transferrin or IgG (Figures 5H and S5H). Intravenous 
injection of serum from NZWxBXSB lupus prone mice, containing circulating 
autoantibodies (Kahn et al., 2008) also resulted in a dose-dependent and FcγRIV-dependent 
activation of kidney macrophages (Figure 5I). Finally, to investigate whether complement is 
required for macrophage activation in response to SIC, we analysed Cfb-, C3-, C5aR- and 
C5aR/C3aR-deficient mice injected with rabbit anti-mouse albumin (Ra-mAlbumin, as in 
Figure 5H). SIC-induced TNF production by macrophages in these animals was not different 
than in wild-type controls (Figure S5I) suggesting that complement is not required at this 
stage of macrophage activation.
Altogether these data strongly suggested that circulating SIC access the interstitium through 
caveolae-mediated transport across the endothelium of peritubular capillaries, where they are 
scavenged by kidney resident macrophages resulting in FcγRIV-mediated, but Myd88- and 
complement-independent macrophage activation.
Selective recruitment of monocytes and neutrophils in the kidney by SIC-activated 
resident macrophages
Intravenous injection of SIC also resulted, over the following 6 hours, in a progressive 
accumulation of Ly6Chigh monocytes, Ly6Clow patrolling monocytes, and neutrophils in the 
kidney (Figures 6A, 6B and S6A), but not in the dermis (Figure S6B) as quantified by flow 
cytometry and intravital microscopy. This leucocyte recruitment was abrogated in Fcgr4−/− 
and LysMCre+;Fcgr4f/f mice (Figure 6A). Intravital imaging confirmed the progressive 
retention of Ly6Clow patrolling monocytes in kidney capillaries over time (Figures S6C–
S6F). Blood monocytes and neutrophils express FcγRIV (Nimmerjahn et al., 2005). 
Therefore to test whether expression of FcγRIV by monocytes and granulocytes was 
required for their recruitment we transferred wild-type and FcγRIV-deficient leucocytes 1 
hour before or 1 hour after SIC injection, and analyzed recruitment 6 hours later. We 
observed a similar recruitment of wild-type and FcγRIV-deficient monocytes and 
granulocytes to the kidney (Figure 6C). To investigate whether lymphoid cells were involved 
in leucocyte recruitment we also performed injection of BSA;RaBSA in 
Rag2−/−Il2rg−/−mice, which lack lymphoid cells (DiSanto et al., 1995; Shinkai et al., 1992). 
Results indicated that Rag2 and Il2rg are dispensable for the recruitment of monocytes and 
neutrophils by SIC (Figure 6D). Finally, monocyte recruitment was independent of Myd88 
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(Figure 6E), although neutrophil recruitment was decreased in Myd88-deficient mice 
(Figure 6F).
These data suggested that SIC trigger the recruitment of monocytes and neutrophils via the 
FcγRIV-dependent activation of kidney resident macrophages. However, granulocyte 
recruitment by SIC was in part dependent on Myd88. This is compatible with the 
observation that kidney resident macrophages activated by circulating SIC produce Il1b, in a 
FcγRIV dependent manner, which may be involved in neutrophil recruitment.
Macrophage FcγRIV-mediated inflammatory response synergizes with TLR signaling when 
SIC contain nucleic acids
To investigate directly the respective roles of Myd88 and FcγRIV signaling in the 
inflammatory response to SIC, we prepared ovalbumin covalently linked to either CpG 
oligonucleotides (OVA-CpG), a potent TLR9 agonist (Hemmi et al., 2002) or non-
stimulatory GpC oligonucleotides (OVA-GpC) as control (Figure 7A). As expected, i.v. 
injection of OVA-GpC;RaOVA induced FcγRIV-dependent macrophage activation - as 
evaluated by TNF production, expression of activation markers, and recruitment of 
monocytes and neutrophils in comparison to OVA-GpC alone (Figures 7B–7G). OVA-CpG 
on its own induced macrophage activation independently of FcγRIV. Moreover, i.v. injection 
of OVA-CpG;RaOVA resulted in a stronger macrophage activation than OVA-CpG alone or 
OVA-GpC;RaOVA in wild- type mice, but identical to OVA-CpG alone in FcγRIV-deficient 
mice (Figures 7B–7G). In this model neutrophil recruitment was mostly attributable to the 
CpG nucleotide (Figure 7D). These data indicate independent, but additive and even 
synergistic, effects of FcγRIV-dependent and TLR pathways on the activation of resident 
macrophages suggesting that Fcgr4-dependent activation of resident macrophages by SIC 
synergises with Myd88 signaling when a TLR activating signal is present.
Discussion
We report here a comprehensive set of studies describing a tissue specific anatomical and 
functional unit, formed by resident macrophages and peritubular capillary endothelial cells, 
which monitor the transport of proteins and particles ranging from 20 to 700 kDa or 10 to 
200 nm into the kidney interstitium (Figure 7H). This allows kidney resident macrophages to 
immediately detect potential infectious particles, in this case immune complexes, and to 
initiate an immune response.
Our observations thus provide a simple model to explain type III hypersensitivity to SIC in 
the kidney, and show that it is governed by a mechanism distinct from the Arthus reaction in 
the skin mediated by mast cells (Hazenbos et al., 1996; Nimmerjahn et al., 2010; Sylvestre 
and Ravetch, 1996). It is also distinct from immune complex-mediated arthritis (Binstadt et 
al., 2006), from immune complex-mediated peritonitis (Hasenberg et al., 2015) and from 
immune complex-mediated inflammation in the cremaster muscle (Stokol et al., 2004).
The ‘tissue-specific’ role of macrophages in type III reactions in the kidney can be 
accounted for by their unique subendothelial location in comparison to the dermis, the 
relatively selective expression of FcγRIV, the renal blood flow to the kidneys representing 
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25% of cardiac output, and by the higher surface density of transendothelial channels in the 
kidney capillary bed and higher albumin transport to the interstitium (Milici et al., 1985). 
The latter was calculated in classical studies to be of 7.1 ± 1-0 ml. sec−1 10−4 in 100 g 
cortical tissue (Bell et al., 1978), which accounts for the higher concentration of albumin in 
the interstitium of the kidney cortex (Bell et al., 1978; Källskog and Wolgast, 1973; Pinter, 
1967; Pinter and O’Morchoe, 1970), and was proposed to facilitate tubular reabsorption of 
fluid and small solutes (Milici et al., 1985).
Nevertheless, clearance of the capillary filtrate by perivascular macrophages is not unique to 
the kidney and was also observed in muscle. Observations by Bruns and Palade established 
that adventitial macrophages in the rat diaphragm take up ferritin from circulation following 
i.v. injection (Bruns and Palade, 1968). In addition, our observation that transendothelial 
transport is a rapid process is not unique. The group of G. Palade showed that albumin can 
be transcytosed within 15 seconds after perfusion in the endothelium and pericapillary 
spaces of myocardial capillaries (Milici et al., 1987), and more recent work demonstrated 
‘pumping’ of antibody via caveolae across the lung endothelium 10 seconds after i.v. 
injection (Oh et al., 2007).
The present study may also shed some light on the debate about the functional consequences 
of uptake of SIC or aggregated IgG by macrophages. In vitro, complexed IgG or immune 
complexes alone did not elicit an inflammatory response from monocyte-derived 
macrophages in the absence of a TLR agonist, and were proposed to serve an anti-
inflammatory role (Sutterwala et al., 1997; Vogelpoel et al., 2014). However, in vivo studies 
show in a diversity of models that genetic deletion of activating FcγRs can decrease 
inflammatory responses in mice (Clynes et al., 1998; Kaneko et al., 2006; Nimmerjahn et 
al., 2010; Sylvestre and Ravetch, 1994). Our results suggest that in vivo and at least in the 
kidney, SIC and aggregated IgG can indeed initiate an FcγRIV-dependent Myd88-
independent inflammatory response.
Altogether, our observations identify a physiological ‘monitoring’ function of tissue resident 
macrophages in the kidney interstitium, and a simple model to explain how SIC initiate 
kidney inflammation. Sampling of the capillary filtrate by macrophages is not inflammatory 
per se. However, cognate recognition of SIC by the kidney macrophages mediates increased 
scavenging and a FcγRIV-dependent cellular immune response, which can synergize with 
Myd88 signaling when SIC contain nucleic acids. These data may carry significant 
implications for the understanding and prevention of kidney pathologies mediated by SIC, 
and possibly other nanometer-sized particles.
Experimental Procedures
Mice
Animal procedures were performed in adherence with the Institutional Review Board 
(IACUC 15-04-006) at MSKCC. Mice were maintained under SPF conditions. Mouse 
strains are described in Extended Experimental Procedures.
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Antibodies used for flow cytometry are described in Extended Experimental Procedures. 
Chicken ovalbumin (OVA)-alexa555, bovine serum albumin (BSA)-alexa488, BSA-TRITC, 
DQ Green-BSA, 70kD TRITC-conjugated dextran and carboxylate-modified 2, 0.2 or 0.02 
μm beads were purchased from Invitrogen (Carlsbad, CA). Endotoxin-free OVA (Hyglos) 
was conjugated to CpG 1668 or GpC 1668 oligonucleotides (both from Invivogen) as 
described in Extended Experimental Procedures. Polyclonal rabbit anti-OVA and polyclonal 
rabbit anti-BSA were purchased from AbD Serotec and Invitrogen respectively, and their 
affinity for murine FcγRs was determined with a Biacore X100 biosensor system as 
previously described (Kao et al., 2015), using a 1:1 Langmuir binding model as rabbits have 
only one IgG class (Rayner et al., 2013). Immune complexes containing OVA and BSA were 
prepared in vitro, as described in Extended Experimental Procedures, and analyzed by fast 
protein liquid chromatography using a ÄKTA FPLC system (GE Healthcare Life Sciences). 
Polyclonal rabbit anti-mouse serum albumin (#600-401-254), polyclonal rabbit anti-mouse 
transferrin (#600-401-255), polyclonal rabbit anti- mouse IgG (#610-4102) and polyclonal 
rabbit anti-mouse IgG F(ab′)2 (#310-4102) were purchased from Rockland 
Immunochemicals.
Intravenous injection of Immune complexes, albumin, antibodies, and latex beads
Immune complexes, albumin and antibodies were resuspended in PBS and injected i.v. in 
volume of 100 μl. See also Extended Experimental Procedures.
Flow cytometry
Flow cytometry was performed as described in Extended Experimental Procedures. Data 
were acquired using a BD LSRFortessa flow cytometer, and analysed using FlowJo 9.5 (Tree 
Star Inc.).
Intravital Microscopy of the Kidney
Intravital confocal microscopy of kidney was performed as previously described (Auffray et 
al., 2007; Carlin et al., 2013). Briefly, mice were anesthetized, kept at 37°C and received 
oxygen (0.5 L/min). The left kidney was surgically exposed after a left flank incision, 
without removing the renal capsule or interrupting the blood flow. See also Extended 
Experimental Procedures.
Transmission Electron Microscopy
The full methods for TEM are described in Extended Experimental Procedures. In brief, 
kidneys were dissected and fixed in 5% acrolein and 4% formaldehyde. Sections were 
stained for rabbit IgG, Cx3cr1-gfp or MHC-II using gold-conjugated goat anti-rabbit 
(Nanoprobes) and examined at 80kV with a FEI Tecnai Spirit G2 TEM equipped with an 
ORCA-HR digital camera (10 MP; Hamamatsu). Peritubular capillaries and their 
surroundings were randomly photographed at 4,800x or 6,800x, for a total surface of 
~10,000 μm2 sampled in 3 animals, and all the immunogold particles in the pictures were 
counted.
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Two-tailed unpaired t test was used to calculate statistical significance, using Prism 6 
software (GraphPad). p values from unpaired Student’s t test are indicated in the figure 
legends.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Uptake of immune complexes by kidney macrophages
(A) Flow cytometric analysis of BSA-alexa488 uptake by macrophages from C57BL/6 mice 
injected i.v. with 50 μg BSA-alexa488 or BSA-alexa488;RaBSA (50 μg BSA-alexa488 
+ 110 μg RaBSA) 2 hours prior to analysis. Scatter plots (top: geometric mean fluorescent 
intensity, MFI) and representative histograms (bottom) N = 2–6 mice per treatment. (B) 
Uptake of BSA-TRITC by kidneys leukocytes from Cx3cr1gfp/+mice injected i.v. with BSA-
TRITC;RaBSA (50 μg BSA-TRITC + 110 μg RaBSA) 2 hours prior to analysis. Plots are 
representative of 10 mice. (C) Uptake of BSA-TRITC as in (B) by kidney leukocytes in 
Cx3cr1gfp/+ Rag2−/− Il2rg−/− mice 2 hours after i.v. injection of increasing amounts of BSA-
TRITC or BSA-TRITC;RaBSA. N = 2–6 mice per treatment, per dose. (D) As in (C) for 
increasing amounts of OVA-alexa555 or OVA-alexa555;RaOVA. N = 2–8 mice per 
treatment, per dose. (E) BSA-alexa488 uptake by kidney F4/80bright macrophages injected 
i.v. with PBS, 50 μg BSA-alexa488, BSA-alexa488;RaOVA or BSA-alexa488;RaBSA 2 
hours prior to analysis as in (A). N = 3–6 mice per treatment. (F) Still frame from intravital 
imaging (IVM) of the superficial renal cortex of a Cx3cr1gfp/+ mouse 2 hours after i.v. 
injection of 50 μg BSA-TRITC;RaBSA as in (C). N = 10 mice. Bar = 10 μm. (G) Flow 
cytometric analysis of DQ-BSA fluorescence in kidney F4/80bright macrophages 2 hours 
after i.v. injection of 12.5 μg DQ-BSA or DQ-BSA;RaBSA (12.5 μg DQ-BSA + 27.5 μg 
RaBSA). N = 3–6 mice per treatment. Bars indicate mean value ± S.E.M. Symbols represent 
individual mice. *P < 0.05, **P < 0.01, ***P < 0.001 using a two-tailed, unpaired t-test. See 
also Figure S1.
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Figure 2. Kidney F4/80bright cells are tissue resident macrophages
(A) Immunofluorescence (IF) staining for F4/80, CD31 and rabbit IgG in kidney 
cryosections from a C57BL/6 mouse injected i.v. with BSA;RaBSA (50 μg BSA + 110 μg 
RaBSA) 2 hours prior to euthanasia. N = 3 mice. (B) IF staining for F4/80 and mouse IgG2a 
in kidney cryosections from a 6-month old NZBxW F1 mouse. G, glomerulus; T, tubule. 
Arrows indicate co-localistion of F4/80 and IgG2a staining. (C) IF staining for F4/80, CD31 
and FcγRIV in kidney cryosections from C57BL/6, Fcgr4−/− and LysMCre+;Fcgr4f/f mice. 
(D) CD45.1 and CD45.2 congenic mice analyzed on 3, 5 or 8 weeks of parabiosis. 
Histograms represents percentage of partner-derived cells in the spleen, kidney and blood. N 
= 2–4 parabionts per time point. Bars indicate mean value ± S.E.M. Symbols represent 
individual mice. (E–F) Still frames from IVM of the superficial renal cortex in Cx3cr1gfp/+ 
Rag2−/− Il2rg−/− mice. Capillaries are visualized by i.v. injection of 70 kDa dextran-TRITC. 
Arrow in (F) indicates macrophage filopodial extension. Time in (F) is shown in min:sec. 
Bars = 10 μm (A, E, F) or 50 μm (B, C). See also Figure S2 and supplementary movies S1–
S3.
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Figure 3. Kidney resident macrophages are located between the capillary endothelium and the 
basement membranes of tubules and the Bowman capsule
(A) 3D surface rendering of a still frame form IVM of the kidney in a Cx3cr1gfp/+ Rag2−/− 
Il2rg−/− mouse. Cx3cr1gfp macrophage is in green. Capillaries (red) are visualized in red by 
i.v. injection of 70 kDa dextran-TRITC. (B) Transmission Electron Microscopy (TEM) 
image of the kidney cortex from a C57BL/6 mouse. MΦ: macrophage, E: endothelium, T: 
tubule. Inset shows endothelial plasmalemmal vesicles. (C–D) TEM images of the renal 
cortex in a Cx3cr1gfp/+ mouse immunostained for GFP. MΦ: macrophage, E: endothelium, 
T: tubule. (E–G) TEM images of the renal cortex in a C57BL/6 mouse immunostained for I-
A. MΦ: macrophage, E: endothelium, PT: proximal tubule, DT: distal tubule, T: tubule, P: 
podocyte foot processes. Bars = 10 μm (A), 1 μm (B–H), 0.5 μm (inset in B). See also Figure 
S3. (H) Scheme giving the anatomical context of EM pictures. Capillaries are depicted in 
red, macrophage in blue, podocytes in green and epithelial structures in grey, PT: proximal 
tubule, DT: distal tubule. The area corresponding to EM pictures in E and F is indicated by a 
dashed black line.
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Figure 4. Macrophages monitor transendothelial transport of circulating immune complexes
(A) Still frames from IVM of the kidney from Cx3cr1gfp/+ mouse receiving 50 μg OVA-
alexa555 i.v.. Arrows indicate OVA-positive macrophage. Time is min:sec from the time of 
i.v. injection. Bar = 10 μm. (B) As in (A) 10 minutes after i.v. injection of 10 μg PE-
conjugated antibodies against F4/80 (top) and I-A (bottom). Bars = 20 μm. N = 3–4 mice per 
antibody. (C) Flow cytometry analysis of kidney leucocytes from Cx3cr1gfp/+ mice 
sacrificed 5 minutes after i.v. injection of 10 μg anti-I-A. N = 6 mice. (D) TEM of the kidney 
cortex from mice sacrificed 30 seconds after i.v. injection of OVA;RaOVA. RaOVA is 
detected with gold-conjugated goat anti-rabbit. Arrow indicates gold particles in endothelial 
caveolae/CCV. Macrophages are identified by immunocytochemistry for I-A. MΦ: 
macrophage, E: endothelium, T: tubule. Bars = 0.5 μm. (E) Quantification of total (left) and 
endothelium-associated (right) immunogold particles in mice treated in (D). The numbers 
above bars indicate the absolute number of gold particles counted in total N = 3 mice. (F) 
Still frame from IVM of phagocytosis of 0.02 μm beads by a kidney macrophage in 
Cx3cr1gfp/+ mice. Bar = 10 μm. (G) Phagocytosis of 2, 0.2 and 0.02 μm beads by splenic 
RPMΦs (left) and kidney macrophages (right) 2 hours after i.v. injection. N = 5–12 per 
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treatment. (H) Still frames from IVM of the superficial renal cortex in C57BL/6 mice 
injected i.v. with 70 kDa dextran-TRITC to label the vascular bed (red), and 5–7 min later, 
with BSA, or BSA;RaBSA (50 μg/mouse). Images are shown immediately before and 10 
minutes after injection of BSA, or BSA;RaBSA. Bars = 100 μm. Each symbol in (C) and 
(G) represents an individual mouse. See also Figure S4 and supplementary movies S4–S7.
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Figure 5. FcγRIV-dependent uptake and activation of kidney, but not dermal, macrophages by 
small immune complexes, ‘auto’ antibodies, and NZWxBXSB serum
(A) Uptake of OVA-alexa555 by kidney macrophages from wt, Fcgr1−/−, Fcgr4−/− and 
LysMCre+;Fcgr4f/f mice 2 hours after i.v. injection of 6.5 μg OVA-alexa555 or OVA-
alexa555;RaOVA (6.5 μg OVA-alexa555 + 21.25 μg RaOVA). N = 3–7 mice per treatment, 
per genotype. (B) Uptake of BSA-TRITC by kidney F4/80bright macrophages from wt, 
Csf1rCre+;Fcgr4f/f and Csf1rCre−;Fcgr4f/f mice 2 hours after i.v. injection of 50 μg BSA-
TRITC or BSA-TRITC;RaBSA. N = 3 mice per treatment, per genotype. (C) qPCR analysis 
of IL-6, Il-1b, Tnf, Ccl2 transcripts in total kidney tissue from C57BL/6 mice 1, 3, and 6 hrs 
after i.v. injection of 50 μg BSA-TRITC or BSA-TRITC;RaBSA. N = 4–6 mice per 
treatment, per time point. (D) qPCR for Tnf and Il1b in FACS-sorted kidney F4/80bright 
macrophages from wt (C57BL/6) and Fcgr4−/− mice 1 hour after treatment. N = 6–7 mice 
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per treatment, per genotype. (E–F) Representative plots (E) and quantification (F) of 
intracellular staining for TNF in kidney F4/80bright macrophages from wt and Fcgr4−/− mice 
1 hour after treated as in (D). N = 5–7 mice per treatment, per genotype. (G) TNF staining in 
kidney and dermal F4/80bright macrophages from wt mice 1 hour after treatment as in (D). N 
= 3–8 mice per treatment. (H) TNF staining in kidney F4/80bright macrophages from wt 
mice 1 hour after i.v. injection of the indicated amounts of BSA, RaBSA, BSA;RaBSA, 
rabbit IgG (Ra-IgG), rabbit anti-mouse transferrin (Ra-mTransferrin), rabbit anti-mouse 
albumin (Ra-mAlbumin), rabbit anti-mouse IgG (Ra-mIgG) or Ra- mIgG (Fab′)2. N = 4–5 
mice per treatment. (I) TNF staining in kidney F4/80bright macrophages from wt or Fcgr4−/− 
mice 1 hour after i.v. injection of increasing amounts of serum from the indicated mouse 
strains. N = 2–5 mice per dose per genotype. Bars indicate mean value ± S.E.M. Each 
symbol represents an individual mouse. *P < 0.05, **P < 0.01, ***P < 0.001 using a two-
tailed, unpaired t-test. NS, not significant. See also Figure S5.
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Figure 6. FcγRIV-dependent activation of kidney macrophage by immune complexes triggers 
recruitment of blood leucocytes
(A) Recruitment of total monocytes, Ly6Chigh monocytes and neutrophils in the kidneys of 
wt, Fcgr4−/−, LysMCre−;Fcgr4f/f and LysMCre+;Fcgr4f/f mice, assessed by flow cytometry 6 
hours after i.v. injection of 50 μg BSA-TRITC or BSA-TRITC;RaBSA. N = 3–7 mice per 
treatment, per genotype. (B) Intravital microscopy analysis of neutrophil recruitment in the 
kidneys of Cx3cr1gfp/+ Rag2−/− Il2rg−/− mice (detected by i.v. injection of APC-conjugated 
anti-Gr1 antibody) 6 hours after i.v. injection of 50 μg BSA or BSA;RaBSA. N = 4–5 mice 
per treatment, per genotype. Bars = 50 μm. (C) Recruitment of CD45.2 bone marrow 
leucocytes transferred from wt or Fcgr4−/− mice into wt CD45.1 recipients 1hr before or 1 hr 
after i.v. injection of 50 μg BSA-TRITC or BSA-TRITC;RaBSA. Recruitment is measured 6 
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hours after treatment. N = 7–10 mice per treatment, per genotype, per time point of transfer. 
(D) Recruitment of total monocytes, Ly6Chigh monocytes and neutrophils (PMNs) in the 
kidneys of Cx3cr1gfp/+ Rag2−/− Il2rg−/− mice 6 hours after treated as in (A). N = 4–10 mice 
per treatment. (E–F) Recruitment of total monocytes (E) and neutrophils (F) in the kidneys 
of Myd88+/− or Myd88−/− littermates treated as in (A). N = 4–7 mice per treatment, per 
genotype. Each symbol represents an individual mouse. **P < 0.01, ***P < 0.001 using a 
two-tailed, unpaired t-test. NS, not significant. See also Figure S6.
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Figure 7. FcγRIV-dependent activation of macrophages by immune complexes synergizes with 
TLR signalling
(A) C57BL/6 or Fcgr4−/− mice were injected i.v. with 12.5 μg OVA-GpC, 12.5 μg OVA-
CpG, OVA-GpC;RaOVA (12.5 μg OVA-GpC + 42.5 μg RaOVA) or OVA-CpG;RaOVA (12.5 
μg OVA-CpG + 42.5 μg RaOVA). (B–D) Flow cytometric analysis of Ly6Chigh monocyte 
(B), Ly6Clow monocyte (C) and neutrophil (D) recruitment (per mg of tissue) in the kidneys 
of C57BL/6 or Fcgr4−/− mice assessed by flow cytometry 6 hours after treatment as in (A). 
(E) Intracellular staining for TNF in kidney leukocytes from C57BL/6 mice 1 hour after 
treatment as in (A). (F–G) Flow cytometric analysis of CD86 (F) and I-A (G) expression by 
F4/80bright kidney macrophages 2 hours after treatment as in (A). N = 3–9 mice per 
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treatment, per genotype. Bars indicate mean value ± S.E.M. Symbols represent individual 
mice. *P < 0.05, **P < 0.01, ***P < 0.001 using a two-tailed, unpaired t-test. NS, not 
significant.
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